Pimecrolimus cream 1% for papulopustular rosacea: A randomized vehicle-controlled double-blind trial

British Journal of Dermatology

Volumn 156, Issue 4, 2007, Pages 728-732

  Weissenbacher, S ^a   Merkl, J ^a   Hildebrandt, B ^a   Wollenberg, A ^b   Braeutigam, M ^c   Ring, J ^a   Hofmann, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Novartis Pharma   (Germany)

Author keywords

Pimecrolimus; Randomized controlled trial; Rosacea

Indexed keywords

PIMECROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ERYTHEMA; FEMALE; HUMAN; MALE; PAPULE; PHOTOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; ROSACEA; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, TOPICAL; ADULT; AGED; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; ROSACEA; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME; VEHICLES;

EID: 33947415805     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07669.x     Document Type: Article

References (29)

1. Powell FC. Rosacea. N Engl J Med 2005; 352:793-803.
2. Wilkin J, Dahl M, Detmar M et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46:584-7.
3. Plewig G, Kligman AM. Acne and Rosacea, 3rd edn. Berlin: Springer-Verlag, 2000.
4. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51:327-41.
5. Dahl MV, Ross AJ, Schlievert PM. Temperature regulates bacterial protein production: possible role in rosacea. J Am Acad Dermatol 2004; 50:266-72.
6. Grilli R, Fernandez M. Helicobacter pylori: related to rosacea? J Am Acad Dermatol 2000; 42:536-7.
7. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004; 51:499-512.
8. Heymann WR. Rosacea subtype-directed therapy. J Am Acad Dermatol 2004; 51:90-2.
9. Dahl MV, Jarrat M, Kaplan D et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001; 45:723-30.
10. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003; 48:836-45.
11. Torresani C, Pavesi A, Manara GC. Clarithromycin vs. doxycycline in the treatment of rosacea. Int J Dermatol 1997; 36:942-6.
12. Bakar Ö, Demircay Z, Oya G. Therapeutic potential of azithromycin in rosacea. Int J Dermatol 2004; 43:151-4.
13. Hofer T. Continuous 'microdose' isotretinoin in adult recalcitrant rosacea. Clin Exp Dermatol 2004; 29:196-205.
14. Goldmann D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001; 44:995-8.
15. Chu CY. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Br J Dermatol 2005; 152:396-9.
16. Cunha PR, Rossi AB. Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. Acta Derm Venereol (Stockh) 2006; 86:71-2.
17. Crawford KM, Russ B, Bostrom P. Pimecrolimus for treatment of acne rosacea. Skinmed 2005; 4:147-50.
18. Kim BS, Chang SH, Cho MK. Safety and efficacy of pimecrolimus cream in adults with erythematotelangiectatic rosacea. J Eur Acad Dermatol Venereol 2005; 19 (Suppl. 2): 76 (abstr.).
19. Gupta AK, Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003; 17:493-503.
20. Grassberger M, Steinhoff M, Schneider D, Luger TA. Pimecrolimus - an anti-inflammatory drug targeting the skin. Exp Dermatol 2004; 13:721-30.
21. Wollenberg A, Oppel T. Scoring of skin lesions with the Perioral Dermatitis Severity Index (PODSI). Acta Derm Venereol (Stockh) 2006; 86:251-2.
22. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-16.
23. Wollenberg A, Pavicic T, Wetzel S et al. Pimecrolimus cream 1% is effective in rosacea-like perioral dermatitis - results of a randomized, double blinded, vehicle controlled clinical trial involving 40 patients. J Eur Acad Dermatol Venereol 2005; 19 (Suppl. 2): 8 (abstr.).
24. Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg 2001; 20:199-206.
25. Millikan LE. Rosacea as an inflammatory disorder: a unifying theory? Cutis 2004; 73:5-8.
26. Bamford JT, Elliott BA, Haller IV. Tacrolimus effect on rosacea. J Am Acad Dermatol 2004; 50:107-8.
27. Bamford JT, Gessert CE, Renier CM. Measurement of the severity of rosacea. J Am Acad Dermatol 2004; 51:697-703.
28. Pflugshaupt C. Eigenwirkung von Vehikeln - Systematik und Gedanken zur Vehikelwahl. Deutsche Dermatologe 1992; 40:1144-55.
29. Fluhr JW, Rigano L. Clinical effects of cosmetic vehicles on skin. J Cosmet Sci 2004; 55:189-205.